Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia

NCT02998645 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Aplastic Anemia

Interventions

DRUG: eltrombopag
DRUG: Cyclosporine

Sponsor

Novartis Pharmaceuticals